Breadcrumb Home IMPAACT News IMPAACT News News June 2024 Announcements Spotlight Series Social Behavioral Scientific Core (SBSC) SpotLight Series: June 2023 June 2024 Announcements European Medicines Agency Approves Triumeq PD® for Infants and Young Children Based on IMPAACT Data May 2024 Announcements IMPAACT Network Manual of Procedures Version 5.0 is Now Available Search Enter a search term. Filter Topics AllAnnouncementsMeetingsSpotlight SeriesStudy Results Date All202420232022202120202019201820162014 Sort Date AscDate Desc Submit Search Showing 85 news items. February 2021 Announcements IMPAACT 2032 Funded by the NIH to Evaluate Remdesivir for COVID-19 in Pregnancy February 2021 Meetings IAS 2021 abstract submissions extended to 15 February January 2021 Announcements IMPAACT MOP Updated January 2021 Announcements IMPAACT at R4P 2021 November 2020 Announcements IMPAACT Award November 2020 Announcements IMPAACT 2007 informs U.S. FDA approval of two supplements September 2020 Meetings Key Dates for CROI 2021 June 2020 Study Results IMPAACT P1093 Informs FDA Decision to Approve First-ever Dolutegravir Dispersible Tablet for Treatment of Children living with HIV June 2020 Announcements Statement from IMPAACT Leadership on Longstanding Racial Injustice March 2020 Meetings COVID-19 Resources Pagination Previous page Prev Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Current page 7 Page 8 Page 9 Next page Next
June 2024 Announcements Spotlight Series Social Behavioral Scientific Core (SBSC) SpotLight Series: June 2023
June 2024 Announcements European Medicines Agency Approves Triumeq PD® for Infants and Young Children Based on IMPAACT Data
February 2021 Announcements IMPAACT 2032 Funded by the NIH to Evaluate Remdesivir for COVID-19 in Pregnancy
June 2020 Study Results IMPAACT P1093 Informs FDA Decision to Approve First-ever Dolutegravir Dispersible Tablet for Treatment of Children living with HIV